HBV Citations List: December 2022
Literature Citations
1. Antiviral Activities of Polygonum perfoliatum L. Extract and Related Phenolic acid Constituents against Hepatitis B Virus. Chen, Z., Y. Yuan, D. Yang, M. Luo, Q. Liang, Z. Li, S. Lu, J. Sun, M. Deng, M. Liu, Z. Liang, and K. Liu. Journal of Medical Virology, 2022. 94(12): p. 5987-5999. PMID[36000452].
[PubMed]. HBV_12_2022.
2. Preclinical Characterization of a Novel Class of Highly Potent Small Molecule Hepatitis B and D Virus Entry Inhibitors. Contreras, H., D. Azimova, J. Tan, N. Unchwaniwala, L.D. Guo, M. Shen, J.X. Yu, M.P. Windisch, X. Xu, M. Perron, M. Walker, W. Delaney, and M. Zhong. Hepatology, 2022. 76: p. S259-S259. ISI[000870796600305].
[WOS]. HBV_12_2022.
3. Characterization of a KDM5 Small Molecule Inhibitor with Antiviral Activity against Hepatitis B Virus. Gilmore, S.A., D. Tam, T.L. Cheung, C. Snyder, J. Farand, R. Dick, M. Matles, J.Y. Feng, R. Ramirez, L. Li, H. Yu, Y. Xu, D. Barnes, G. Czerwieniec, K.M. Brendza, T.C. Appleby, G. Birkus, M. Willkom, T. Kobayashi, E. Paoli, M. Labelle, T. Boesen, C.H. Tay, W.E.t. Delaney, G.T. Notte, U. Schmitz, and B. Feierbach. Public Library of Science One, 2022. 17(12): e0271145. PMID[36477212]. PMCID[PMC9728921].
[PubMed]. HBV_12_2022.
4. Compound IMB-Z Inhibits Hepatitis B Virus Replication through Increasing APOBEC3G Expression and Incorporation into Viral Nucleocapsids. Hu, J., H. Wang, L. Yang, S. Wu, Y. Li, Y. Li, and Z. Li. Journal of Global Antimicrobial Resistance, 2022. 31: p. 371-378. PMID[36396043].
[PubMed]. HBV_12_2022.
5. New Thiourea Derivatives as Potent Inhibitors of Hepatitis B Virus for Therapeutic Targeting. Kumar, J. and V. Kumar. Hepatology, 2022. 76: p. S316-S317. ISI[000870796601030].
[WOS]. HBV_12_2022.
6. Novel Furanocoumarins Target cccDNA to Inhibit HBV DNA Replication and Viral Gene Expression. Kumar, V. Hepatology, 2022. 76: p. S314-S314. ISI[000870796601027].
[WOS]. HBV_12_2022.
7. Discovery of Benzimidazole Substituted 1, 2, 4-Oxadiazole Compounds as Novel anti-HBV Agents with TLR8-agonistic Activities. Qiu, J., Y. Zou, S. Li, L. Yang, Z. Qiu, F. Kong, and X. Gu. European Journal of Medicinal Chemistry, 2022. 244: 114833. PMID[36228413].
[PubMed]. HBV_12_2022.
8. Design, Synthesis, and Biological Evaluation of Novel Sulfamoylbenzamide Derivatives as HBV Capsid Assembly Modulators. Wang, S., Y. Ren, Q. Li, Y. Wang, X. Jiang, S. Xu, X. Zhang, S. Zhao, D.P. Bradley, M.E. Woodson, F. Zhao, S. Wu, Y. Li, Y. Tian, X. Liu, J.E. Tavis, and P. Zhan. Bioorganic Chemistry, 2022. 129: 106192. PMID[36265355].
[PubMed]. HBV_12_2022.
Patent Citations
This month, no relevant HBV patents were identified.